Modern Chinese Medicine Group Co., Ltd. (Stock Code: 1643) previously announced on 19 January 2026 that it would issue a circular regarding its major transaction involving the acquisition of sale shares. The announcement indicated that the circular would be distributed on or before 9 February 2026 in accordance with Rule 14.41(a) of the Listing Rules.
The company has now stated that additional time is required to finalize information, including the consolidated audited report of the target group for the three years ended 31 December 2025. Consequently, the expected dispatch date for the circular has been delayed to on or before 30 April 2026.
The company has applied for a waiver from strict compliance with Rule 14.41(a) of the Listing Rules; however, the Stock Exchange has not yet granted the waiver as of the date of the announcement. The company will provide further updates as appropriate.
Comments